Cargando…

Is baclofen the least worst option for spasticity management in children?

Baclofen is often considered a first-line treatment option for spasticity management in children. However, adverse effects, administration, and dosing can be barriers to effectiveness. In my practice, other medications for spasticity management are often used prior to initiating baclofen. In this ar...

Descripción completa

Detalles Bibliográficos
Autor principal: Brandenburg, Joline E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116131/
https://www.ncbi.nlm.nih.gov/pubmed/36938744
http://dx.doi.org/10.3233/PRM-230001
_version_ 1785028357803474944
author Brandenburg, Joline E.
author_facet Brandenburg, Joline E.
author_sort Brandenburg, Joline E.
collection PubMed
description Baclofen is often considered a first-line treatment option for spasticity management in children. However, adverse effects, administration, and dosing can be barriers to effectiveness. In my practice, other medications for spasticity management are often used prior to initiating baclofen. In this article, baclofen use for spasticity management in children is briefly reviewed along with discussion of approaches using other medications as first-line treatment options. I will present a rationale for medication selection for spasticity management and discuss the approaches I take in medication selection that incorporate spasticity severity, patient goals, and medication side effect profiles.
format Online
Article
Text
id pubmed-10116131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-101161312023-04-21 Is baclofen the least worst option for spasticity management in children? Brandenburg, Joline E. J Pediatr Rehabil Med Invited Position Paper Baclofen is often considered a first-line treatment option for spasticity management in children. However, adverse effects, administration, and dosing can be barriers to effectiveness. In my practice, other medications for spasticity management are often used prior to initiating baclofen. In this article, baclofen use for spasticity management in children is briefly reviewed along with discussion of approaches using other medications as first-line treatment options. I will present a rationale for medication selection for spasticity management and discuss the approaches I take in medication selection that incorporate spasticity severity, patient goals, and medication side effect profiles. IOS Press 2023-04-06 /pmc/articles/PMC10116131/ /pubmed/36938744 http://dx.doi.org/10.3233/PRM-230001 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Position Paper
Brandenburg, Joline E.
Is baclofen the least worst option for spasticity management in children?
title Is baclofen the least worst option for spasticity management in children?
title_full Is baclofen the least worst option for spasticity management in children?
title_fullStr Is baclofen the least worst option for spasticity management in children?
title_full_unstemmed Is baclofen the least worst option for spasticity management in children?
title_short Is baclofen the least worst option for spasticity management in children?
title_sort is baclofen the least worst option for spasticity management in children?
topic Invited Position Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116131/
https://www.ncbi.nlm.nih.gov/pubmed/36938744
http://dx.doi.org/10.3233/PRM-230001
work_keys_str_mv AT brandenburgjolinee isbaclofentheleastworstoptionforspasticitymanagementinchildren